Structure Therapeutics, Inc. (GPCR)

21.71 +0.52 (+2.45%) USD  |  NASDAQ  |  Oct 26, 11:10
More

Structure Therapeutics Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for GPCR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Total Expenses (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Novo Nordisk A/S Upgrade
Pfizer Inc. Upgrade
Viking Therapeutics, Inc. --
Liquidia Corp. Upgrade